ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

436
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
09 Aug 2024 05:52

Downgrading Japan; Stay Defensive; Downgrading Outlook on Global Equities $ACWI to Neutral

Downgrading Japan TOPIX, Nikkei; Stay Defensive; Downgrading Outlook on Global Equities $ACWI $EEM to Neutral; Many Risk-Off Signals increase odds...

Logo
267 Views
Share
05 Aug 2024 07:05

KRX Foreign Holding Weekly (Aug 2nd): Hyundai Glovis, Woori Financial, Korea Aerospace

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Hyundai Glovis, Woori Financial, Korea Aerospace,...

Logo
288 Views
Share
bearishWuXi AppTec
31 Jul 2024 08:55

WuXi AppTec (2359.HK/603259.CH) 24H1- Backlog Looks Good but It May Not Bring a Performance Reversal

​WuXi AppTec aims to reassure investors in 24H1 report,highlighting resilience amid geopolitical risks.But US supply chain security is bipartisan...

Logo
387 Views
Share
bullishAlteogen Inc
31 Jul 2024 07:05

KRX New Deal Index Rebalance Preview: Potential Changes as Review Period Ends Today

We expect at least 1 change for each of the Secondary Battery, Bio, Internet, Game and BBIG indices. Flows are pretty big on some of the stocks and...

Logo
431 Views
Share
29 Jul 2024 07:05

KRX Foreign Holding Weekly (Jul 26th): Sk Hynix, Samsung Electronics

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Sk Hynix, Samsung Electronics.

Logo
321 Views
Share
x